Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic cervical cancer patients. The trial enrolled patients with confirmed ...

Kerala has reported a cervical cancer prevalence of 7.9% among women, raising concern over delayed screening and low HPV vaccination rates. Health experts stress that regular Pap smears, HPV testing, ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced that the latest long-term survival analysis data from the China ...

Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

Cervical cancer is one of the most preventable forms of cancer, yet it continues to impact thousands of women in the United States each year. An estimated 13,360 women were diagnosed with cervical ...

Cervical cancer is a devastating reality for women in Uganda and throughout Sub-Saharan Africa, ranking as one of the leading causes of cancer-related deaths in the region. It represents ...

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...